TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD

E. Monso Molas (Sabadell, Spain), K. Opron (Ann Arbor, United States of America), O. Sibila (Barcelona Arbor, Spain), R. Faner (Barcelona Arbor, Spain), T. Gabaldon (Barcelona Arbor, Spain), L. Perea (Barcelona Arbor, Spain), S. Quero (Madrid, Spain), A. Marin (Badalona, Spain), M. Dominguez Alvarez (Barcelona, Spain), M. Garcia Núñez (Sabadell, Spain), Y. Huang (Ann Arbor, United States of America)

Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Session: Clinical studies of COPD: combination inhalers and much more
Session type: E-poster session
Number: 986
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Monso Molas (Sabadell, Spain), K. Opron (Ann Arbor, United States of America), O. Sibila (Barcelona Arbor, Spain), R. Faner (Barcelona Arbor, Spain), T. Gabaldon (Barcelona Arbor, Spain), L. Perea (Barcelona Arbor, Spain), S. Quero (Madrid, Spain), A. Marin (Badalona, Spain), M. Dominguez Alvarez (Barcelona, Spain), M. Garcia Núñez (Sabadell, Spain), Y. Huang (Ann Arbor, United States of America). TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD. 986

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS
Source: International Congress 2019 – Innovations in care for chronic respiratory conditions
Year: 2019

NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS
Source: International Congress 2019 – Exploring exercise responses in respiratory diseases
Year: 2019


ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017


ASSOCIATION BETWEEN NEUTROPHIL AND PLATELET TO LYMPHOCYTE RATIO AND DISEASE SEVERITY IN STABLE COPD
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD.
Source: Eur Respir J 2006; 27: 1076
Year: 2006


EVALUATION OF THE IMMUNOGLOBULIN G LEVEL AND THE GAMMAGLOBULIN FRACTION OF THE PROTEINOGRAM IN THE COPD EXACERBATOR PHENOTYPE
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019


RELATIONSHIP BETWEEN BLOOD EOSINOPHILS AND EMPHYSEMA IN A COPD POPULATION
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019



BODY COMPOSITION ALTERATIONS AND ENDOTHELIAL DYSFUNCTION IN COPD AND HF.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


THE ASSOCIATION ANALYSIS OF CHEMILUMINESCENCE OF NEUTROPHILS OF THE BLOOD WITH PATHOGENETIC FACTORS OF COPD
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019




BLOOD EOSINOPHILS AND SMOKING HISTORY AFFECT OUTCOME WITH HIGH DOSE N-ACETYLCYSTEINE TREATMENT IN COPD
Source: International Congress 2017 – COPD management
Year: 2017

USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



EVALUATION OF SYSTEMATIC INFLAMMATION, OXIDATIVE STRESS AND ENDOTHELIAL DISFUNCTION IN COPD, ASTHMATIC AND ACO PATIENTS WITH OBESITY.
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


EFFECTS OF AEROBIC AND BREATHING EXERCISES ON CLINICAL CONTROL AND AIRWAY INFLAMMATION IN PERSISTENT ASTHMA
Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease
Year: 2017



IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019